{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:06:42Z","timestamp":1772168802497,"version":"3.50.1"},"update-to":[{"DOI":"10.12688\/f1000research.130522.1","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000}}],"reference-count":25,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019305","name":"Manipal Academy of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019305","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns3:p>\n                    <ns3:bold>Background:<\/ns3:bold>\n                    Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell diseases characterised by myeloid cell growth from one or more lineages. Angiogenesis, in contrast to other subtypes, plays a substantial role in the pathophysiology of primary myelofibrosis (PMF). Research expressing the correlation of microvessel density (MVD), blasts, fibrosis and mast cell count in MPN cases are rarely conducted. We aimed to study the significance of MVD in correlation with CD34 blasts, mast cells and fibrosis in bone marrow biopsies of MPN patients.\n                    <ns3:bold>Methods:<\/ns3:bold>\n                    The current research was a cross sectional study conducted on 66 cases diagnosed as MPN during a six-year period. This comprised of 32 chronic myeloid leukemia (CML), 31 PMF and three essential thrombocythemia (ET) cases. Routine staining along with reticulin stain to look for fibrosis and immunohistochemistry (IHC) using CD34 and mast cell tryptase (MCT) were performed.\n                    <ns3:bold>Results:<\/ns3:bold>\n                    We found increased MVD in PMF, when compared to CML and ET (p = 0.042). Further, mean MVD was observed to be increased with high blast counts (p = 0.036). On follow up, raised mean MVD was seen in those cases with relapse\/deceased as compared to disease-free patients, which was highly significant (p = 0.000).\n                    <ns3:bold>Conclusions:<\/ns3:bold>\n                    Increased MVD score was mostly associated with PMF subtype among all the MPNs. Further, higher MVD was observed to be associated with increased blast count and poor prognosis. With angiogenesis playing a critical role in disease outcome, we now have drugs to regulate angiogenesis that are supported by contemporary research. However, further studies with larger cohorts to establish the theranostic role of MVD in MPNs is recommended.\n                  <\/ns3:p>","DOI":"10.12688\/f1000research.130522.2","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T07:45:07Z","timestamp":1698738307000},"page":"503","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Study of significance of bone marrow microvessel density in myeloproliferative neoplasms in correlation with CD34 blasts, mast cell count and fibrosis"],"prefix":"10.12688","volume":"12","author":[{"given":"Kesiya","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9786-0485","authenticated-orcid":false,"given":"Ranjitha","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5906-5197","authenticated-orcid":false,"given":"Chaithra","family":"G V","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharada","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sneha","family":"Rao A R","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kudurugundi","family":"Basavaraju Vatsala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"599-608","DOI":"10.1016\/j.exphem.2015.06.007","article-title":"Pathogenesis of myeloproliferative neoplasms.","volume":"43","author":"R Skoda","year":"2015","journal-title":"Exp. Hematol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"424-431","DOI":"10.1007\/s11899-017-0411-0","article-title":"Molecular pathogenesis of myeloproliferative neoplasms: Influence of age and gender.","volume":"12","author":"J Patterson-Fortin","year":"2017 Oct","journal-title":"Curr. Hematol. Mal. Rep."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"581-587","DOI":"10.1002\/ajh.23690","article-title":"How common are myeloproliferative neoplasms? A systematic review and meta-analysis.","volume":"89","author":"G Titmarsh","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"i198-i199","DOI":"10.1093\/ije\/dyv096.318","article-title":"Incidence Rates of Myeloproliferative Neoplasms in India-A Hospital Based Study.","volume":"44","author":"S Varma","year":"2015 Oct 1","journal-title":"Int. J. Epidemiol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"15-19","DOI":"10.1016\/S0002-9440(10)64511-7","article-title":"Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity.","volume":"157","author":"L Lundberg","year":"2000 Jul 1","journal-title":"Am. J. Pathol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"162-168","DOI":"10.1111\/j.1365-2141.2007.06885.x","article-title":"Bone marrow microvessel density in chronic myeloproliferative disorders: A study of 115 patients with clinicopathological and molecular correlations.","volume":"140","author":"E Boveri","year":"2008 Jan","journal-title":"Br. J. Haematol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"102420","DOI":"10.1016\/j.bcmd.2020.102420","article-title":"Association of mast cells and bone marrow reticulin fibrosis in patients with bcr-abl negative chronic myeloproliferative neoplasms.","volume":"82","author":"H Keski","year":"2020 May 1","journal-title":"Blood Cells Mol. Dis."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2121-2129","DOI":"10.21037\/tcr.2019.09.29","article-title":"Increased number of mast cells in the bone marrow of chronic myeloid leukemia may herald the pending myeloid transformation-the mast cell is an indicator of myeloid transformation.","volume":"8","author":"P Xu","year":"2019 Sep 1","journal-title":"Transl. Cancer Res."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.17605\/OSF.IO\/E739P","author":"K Thomas","year":"2023","journal-title":"Open Science Framework."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1217-1225","DOI":"10.1016\/j.humpath.2015.05.004","article-title":"Nuclear factor-erythroid 2, nerve growth factor receptor, and CD34-microvessel density are differentially expressed in primary myelofibrosis, polycythemia vera, and essential thrombocythemia.","volume":"46","author":"N Yigit","year":"2015 Aug 1","journal-title":"Hum. Pathol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"426-428","DOI":"10.1093\/ajcp\/101.4.426","article-title":"CD34 lmmunostaining of Bone Marrow Biopsy Specimens Is a Reliable Way to Classify the Phases of Chronic Myeloid Leukemia.","volume":"101","author":"A Orazi","year":"1994 Apr 1","journal-title":"Am. J. Clin. Pathol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"150-157","DOI":"10.1111\/j.1365-2141.2009.07726.x","article-title":"Angiogenesis and vascular endothelial growth factor-\/receptor expression in myeloproliferative neoplasms: Correlation with clinical parameters and JAK2-V617F mutational status.","volume":"146","author":"M Medinger","year":"2009 Jul","journal-title":"Br. J. Haematol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"219-222","DOI":"10.5858\/2005-129-219-EOMCIM","article-title":"Evaluation of mast cells in myeloproliferative disorders and myelodysplastic syndromes.","volume":"129","author":"C Dunphy","year":"2005 Feb","journal-title":"Arch. Path. Lab."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3374-3380","DOI":"10.1182\/blood.V96.10.3374.h8003374_3374_3380","article-title":"Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia.","volume":"96","author":"R Mesa","year":"2000 Nov 15","journal-title":"Am. J. Hematol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"322-328","DOI":"10.1016\/j.bjhh.2014.07.010","article-title":"Increased angiogenesis in primary myelofibrosis: Latent transforming growth factor-\u03b2 as a possible angiogenic factor.","volume":"36","author":"C Ponce","year":"2014 Sep 1","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"966-973","DOI":"10.1309\/FP0N3LC8MBJUFFA6","article-title":"VEGF expression correlates with microvessel density in Philadelphia chromosome-negative chronic myeloproliferative disorders.","volume":"128","author":"U Gianelli","year":"2007 Dec","journal-title":"Am. J. Clin. Pathol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"170-173","DOI":"10.1007\/BF03033732","article-title":"Increased expression of vascular endothelial growth factor (VEGF) in bone marrow of patients with myeloproliferative disorders (MPD).","volume":"9","author":"T Wr\u00f3bel","year":"2003 Sep","journal-title":"Pathol. Oncol. Res."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"393-404","DOI":"10.1007\/s00277-016-2890-9","article-title":"Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms: clinicopathological and molecular correlations.","volume":"96","author":"D Lekovic","year":"2017 Mar 1","journal-title":"Ann. Hematol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2637-2644","DOI":"10.1182\/blood.V95.8.2637.008k07_2637_2644","article-title":"Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.","volume":"95","author":"T Padr\u00f3","year":"2000 Apr 15","journal-title":"Am. J. Hematol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1185-1190","DOI":"10.1080\/1042819032000159915","article-title":"Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): Therapy induced changes and effects on survival.","volume":"45","author":"I Kuzu","year":"2004 Jun","journal-title":"Leuk Lymphoma."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1398-1401","DOI":"10.1038\/sj.bjc.6693515","article-title":"Angiogenesis in myelodysplastic syndromes.","volume":"81","author":"G Pruneri","year":"1999 Dec","journal-title":"Br. J. Cancer."},{"key":"ref23","first-page":"119-127","article-title":"The involvement of Galectins in the modulation of the JAK\/STAT pathway in myeloproliferative neoplasia.","volume":"2","author":"S Koopmans","year":"2012","journal-title":"Am. J. Blood Res."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1513-1520","DOI":"10.1038\/modpathol.3800224","article-title":"Chronic idiopathic myelofibrosis: Independent prognostic importance of bone marrow microvascular density evaluated by CD105 (endoglin) immunostaining.","volume":"17","author":"M Ponzoni","year":"2004 Dec","journal-title":"Mod Pathol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"96-104","DOI":"10.1016\/j.hemonc.2016.07.002","article-title":"The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis.","volume":"9","author":"M Pizzi","year":"2016","journal-title":"Hematol. Oncol. Stem. Cell Ther."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.3390\/cancers13143433","article-title":"The anti-VEGF (R) drug discovery legacy: improving attrition rates by breaking the vicious cycle of angiogenesis in cancer.","volume":"13","author":"D Ribatti","year":"2021 Jul 8","journal-title":"Cancers."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/12-503\/v2\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/12-503\/v2\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/12-503\/v2\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:05:13Z","timestamp":1745625913000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/12-503\/v2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":25,"URL":"https:\/\/doi.org\/10.12688\/f1000research.130522.2","relation":{"has-version":[{"id-type":"doi","id":"10.12688\/f1000research.130522.1","asserted-by":"subject"}],"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.157527.r219646","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.157527.r219647","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.157527.r219646","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.157527.r219647","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/12-503\/v2#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.157527.r219646, Anna Rita Migliaccio, Unit of Microscopic and Ultrastructural Anatomy, University Campus Bio-Medico, Rome, 07 Nov 2023, version 2, indexed","URL":"https:\/\/f1000research.com\/articles\/12-503\/v2#referee-response-219646","order":0,"name":"referee-response-219646","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.157527.r219647, Danijela Lekovic, Medical faculty, University of Belgrade, Belgrade, 08 Feb 2024, version 2, indexed","URL":"https:\/\/f1000research.com\/articles\/12-503\/v2#referee-response-219647","order":1,"name":"referee-response-219647","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"A postgraduate research grant was obtained from the Manipal Academy of Higher Education for partial funding of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}